• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Akebia Therapeutics, Inc. - Common Stock (NQ:AKBA)

1.270 +0.080 (+6.72%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,462,232
Open 1.230
Bid (Size) 1.270 (500)
Ask (Size) 1.280 (2,200)
Prev. Close 1.190
Today's Range 1.205 - 1.280
52wk Range 1.140 - 4.079
Shares Outstanding 174,537,458
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Akebia (AKBA) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Akebia (AKBA) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
AKBA Shares Rise On Clinical Pipeline Optimism As Anemia Drug Gains Traction ↗
February 26, 2026
The company said on Thursday that it now expects its mid-stage trial of AKB-097 in rare kidney diseases to start in the second half of 2026, with initial data expected in 2027. 
Via Stocktwits

Performance

YTD
-18.1%
-18.1%
1 Month
-7.3%
-7.3%
3 Month
-17.5%
-17.5%
6 Month
-57.1%
-57.1%
1 Year
-33.9%
-33.9%

More News

Read More
Akebia Therapeutics Inc (NASDAQ:AKBA) Reports Q4 Revenue Beat and 49% Annual Growth Amid Mixed Market Reaction ↗
February 26, 2026
Via Chartmill
News headline image
Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M ↗
December 01, 2025
Via Stocktwits
News headline image
Earnings Scheduled For November 10, 2025 ↗
November 10, 2025
Via Benzinga
News headline image
An Overview of Akebia Therapeutics's Earnings ↗
November 07, 2025
Via Benzinga
Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion ↗
October 29, 2025
Via Stocktwits
News headline image
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
November 10, 2025
Via Benzinga
News headline image
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗
November 04, 2025
Via Benzinga
News headline image
FDA Pushback Prompts Akebia To Drop Broad Label Pursuit For Kidney Disease Drug ↗
October 29, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
October 29, 2025
Via Benzinga
News headline image
Earnings Preview For Akebia Therapeutics ↗
August 06, 2025
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
May 08, 2025
Via Benzinga
News headline image
Insights Ahead: Akebia Therapeutics's Quarterly Earnings ↗
May 07, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
October 29, 2025
Via Benzinga
News headline image
Mondelez International, Stride, Varonis Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
October 29, 2025
Via Benzinga
News headline image
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket ↗
October 29, 2025
Via Benzinga
News headline image
Wondering what's happening in today's after-hours session? ↗
October 28, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
October 28, 2025
Via Benzinga
News headline image
Akebia (AKBA) Q2 Revenue Jumps 43% ↗
August 07, 2025
Via The Motley Fool
News headline image
9 Health Care Stocks Whale Activity In Today's Session ↗
June 04, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
May 08, 2025
Via Benzinga
News headline image
Here are the top movers in Thursday's session. ↗
March 20, 2025
Via Chartmill
News headline image
Top movers in Thursday's session ↗
March 20, 2025
Via Chartmill

Frequently Asked Questions

Is Akebia Therapeutics, Inc. - Common Stock publicly traded?
Yes, Akebia Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Akebia Therapeutics, Inc. - Common Stock trade on?
Akebia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Akebia Therapeutics, Inc. - Common Stock?
The ticker symbol for Akebia Therapeutics, Inc. - Common Stock is AKBA on the Nasdaq Stock Market
What is the current price of Akebia Therapeutics, Inc. - Common Stock?
The current price of Akebia Therapeutics, Inc. - Common Stock is 1.270
When was Akebia Therapeutics, Inc. - Common Stock last traded?
The last trade of Akebia Therapeutics, Inc. - Common Stock was at 03/06/26 04:00 PM ET
What is the market capitalization of Akebia Therapeutics, Inc. - Common Stock?
The market capitalization of Akebia Therapeutics, Inc. - Common Stock is 221.66M
How many shares of Akebia Therapeutics, Inc. - Common Stock are outstanding?
Akebia Therapeutics, Inc. - Common Stock has 222M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap